M. Ottosson et al., BLOCKADE OF THE GLUCOCORTICOID RECEPTOR WITH RU-486 - EFFECTS IN-VITRO AND IN-VIVO ON HUMAN ADIPOSE-TISSUE LIPOPROTEIN-LIPASE ACTIVITY, Obesity research, 3(3), 1995, pp. 233-240
Cortisol is known to induce lipoprotein lipase (LPL) activity in human
adipose tissue in vitro and in vivo such as in Cushing's syndrome. Th
e significance of the glucocorticoid receptor (GR) for this induction
was evaluated in the present study. The synthetic steroid molecule RU
486, a potent glucocorticoid antagonist, was used as a tool to block t
he GR, in vitro and in vivo. In addition to LPL activity, glucose tole
rance, blood pressure and plasma lipids, all variables influenced by c
ortisol, were studied in order to evaluate the peripheral antiglucocor
ticoid activity of RU 486 in vivo, in man. Addition of both cortisol a
nd RU 486 to incubations of human adipose tissue pieces significantly
inhibited the increase in LPL activity that could be induced by cortis
ol alone (p<0.01). In a ten-fold molarity excess RU 486 totally abolis
hed cortisol action (p<0.01). With cortisol and RU 486 in equimolar co
ncentrations the RU 486 blockade was probably incomplete and LPL activ
ity induced (p<0.05). The results imply that the stimulating effect of
cortisol on LPL activity in human adipose tissue is mediated via the
GR. Administration of 400 mg RU 486 at 2200 hours on two consecutive d
ays to healthy men caused a significant rise in serum cortisol levels
measured at 0800 hours (p<0.05). The mean LPL activity in the subcutan
eous abdominal adipose tissue remained unchanged. The mean level of se
rum triglycerides decreased significantly (p<0.01) and there was a neg
ative correlation between change in LPL activity and change in triglyc
eride levels (r=-0.73, p<0.05). Glucose tolerance and blood pressure w
ere not affected, In conclusion, a total blockade of the GR with RU 48
6 can be achieved in human adipose tissue in vitro. The blockade aboli
shes the stimulating effect of cortisol on LPL activity suggesting tha
t the stimulation is GR dependent. In vivo, with the dose used, the ne
gative pituitary feedback regulation probably compensates for the bloc
kade, at least during the morning hours, thus obviating any peripheral
effect of blockade of the GR.